Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Mylan and PAR – Marketwatch
SAN DIEGO, Jul 17, 2012 (GlobeNewswire via COMTEX) -- Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) , a specialty pharmaceutical company, today announced that it has entered into separate settlement arrangements with Mylan Inc. and its subsidiary ...
Subscribe to LegalLaw247.Com Newsletter